Linear PADRE T Helper Epitope and Carbohydrate B Cell Epitope Conjugates Induce Specific High Titer IgG Antibody Responses
- 1 February 2000
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 164 (3) , 1625-1633
- https://doi.org/10.4049/jimmunol.164.3.1625
Abstract
Linear carbohydrate-peptide constructs based on the 13 amino acid nonnatural pan DR epitope (PADRE) and carbohydrate B cell epitopes are demonstrated to be potent immunogens. These data support our belief that PADRE should be considered as an alternative to more complex carriers for use in prophylaxis and therapeutic vaccines. Two model carbohydrate-PADRE glycoconjugates were used to demonstrate that PADRE could effectively provide T cell help for carbohydrate-specific Ab responses. Conjugates of PADRE covalently linked to the human milk oligosaccharide, lacto-N-fucopentose II or a dodecasaccharide derived from Salmonella typhimurium O-Ag induced high titer IgG Ab responses in mice, which were comparable to glycoconjugates employing human serum albumin (HSA) as the carrier protein. Different adjuvants, in combination with PADRE conjugates, allowed for the modulation of the isotype profile with alum supporting an IgG1 profile; QS-21 an IgG2a, 2b profile, while an alum/QS-21 mixture generated a balanced IgG1/IgG2b isotype profile. As defined by binding to synthetic glycoconjugates, dodecasaccharide-specific Abs exhibited fine specificity similar to protective polyclonal Ab responses previously reported for dodecasaccharide-protein conjugates. The same Abs bound to intact S. typhimurium cells, suggesting that biologically relevant specificities were produced. The affinity of the dodecasaccharide-specific Abs was further shown to be comparable to that of a well-characterized, high affinity monoclonal anti-carbohydrate Ab recognizing the same epitope.Keywords
This publication has 48 references indexed in Scilit:
- Pan DR binding sequence provides T-cell help for induction of protective antibodies against Plasmodium yoelii sporozoitesVaccine, 1999
- Potent immunogenic short linear peptide constructs composed of B cell epitopes and Pan DR T Helper Epitopes (PADRE) for antibody responses in vivoVaccine, 1997
- Effect of conjugation methodology, carrier protein, and adjuvants on the immune response to Staphylococcus aureus capsular polysaccharidesVaccine, 1995
- Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptidesImmunity, 1994
- Immunogenicity in animals of a polysaccharide-protein conjugate vaccine against type III group B Streptococcus.Journal of Clinical Investigation, 1990
- Synthetic immunogens constructed from T-cell and B-cell stimulating peptides (T:B chimeras): Preferential stimulation of unique T- and B-cell specificities is influenced by immunogen configurationCellular Immunology, 1990
- Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cellsEuropean Journal of Immunology, 1989
- Virally induced modulation of murine IgG antibody subclasses.The Journal of Experimental Medicine, 1988
- Immunochemistry ofSalmonellaO-antigens: Studies ofSalmonellaBO antigen epitopes by enzyme-linked immunosorbent inhibition assaysFEMS Microbiology Letters, 1985
- IMPAIRMENT OF THE IMMUNE RESPONSE TO VACCINATION AFTER ACUTE MALARIAThe Lancet, 1978